Compass Therapeutics to Participate in Upcoming June Investor Events
Compass Therapeutics (Nasdaq:CMPX) will participate in two June 2026 investor conferences focused on healthcare.
Rhea-AI Summary
Compass Therapeutics (Nasdaq:CMPX) will participate in two June 2026 investor conferences focused on healthcare.
Management will present at the Jefferies Global Healthcare Conference on June 4 at 8:45 AM ET and the Goldman Sachs 47th Annual Global Healthcare Conference on June 9 at 8:00 AM ET, with webcasts and replays available.
Positive
- None.
Negative
- None.
Details
News Market Reaction – CMPX
In the May 28 session, CMPX gained 6.17%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Jefferies conference date
- June 4, 2026
- Jefferies Global Healthcare Conference presentation date
- Jefferies presentation time
- 8:45 AM ET
- Scheduled start time for Jefferies conference presentation
- Goldman Sachs conference
- 47th Annual
- Goldman Sachs 47th Annual Global Healthcare Conference
- Goldman Sachs date
- June 9, 2026
- Goldman Sachs healthcare conference presentation date
- Goldman Sachs time
- 8:00 AM ET
- Scheduled start time for Goldman Sachs conference presentation
Historical Context
-
Promising CTX-8371 Phase 1 responses with 33% ORR at higher doses.
-
Participation in May biotechnology and oncology investor conferences with webcasts.
-
Q1 results plus positive tovecimig data and cash of $195M with runway into 2028.
-
COMPANION-002 showed improved PFS and ORR for tovecimig plus paclitaxel.
-
Announcement of upcoming webcast to review COMPANION-002 topline secondary endpoints.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of June.
Details are as follows:
Jefferies Global Healthcare Conference
Date: Thursday, June 4, 2026
Time: 8:45 AM ET
Webcast Link: https://cmpx.info/jefferies
Goldman Sachs 47th Annual Global Healthcare Conference
Date: Tuesday, June 9, 2026
Time: 8:00 AM ET
Webcast Link: https://cmpx.info/gs
Virtual/Replay availability: Presentations will be archived on Compass’ Events page.
Compass’ management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.
About Compass Therapeutics
Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, MA. Compass is a clinical-stage, oncology-focused biopharmaceutical company discovering and developing proprietary antibody-based therapeutics to treat multiple diseases. The company’s scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. Compass has a robust pipeline of novel product candidates designed to target multiple key biological pathways to drive an effective anti-tumor response, including angiogenesis modulation, immune activation within the tumor microenvironment, and reduction of tumor-driven immunosuppression. The company is advancing discovery candidates through clinical development to commercial-stage assets. For more information, visit www.compasstherapeutics.com.
Investor Contact
ir@compasstherapeutics.com
Media Contact
Anna Gifford, Chief of Staff
media@compasstherapeutics.com
617-500-8099
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.